viernes, 31 de julio de 2015

Errata: Vol. 64, No. 28

Errata: Vol. 64, No. 28

MMWR Weekly
Vol. 64, No. 29
July 31, 2015
PDF of this issue

Errata: Vol. 64, No. 28


July 31, 2015 / 64(29);806

In the report, "Launch of a Nationwide Hepatitis C Elimination Program — Georgia, April 2015," on page 755, the second sentence should read, "MoLHSA partnered with Gilead Sciences, a pharmaceutical manufacturer that agreed to support the program by providing an initial 5,000 courses of the antiviral medications sofosbuvir (Sovaldi), followed by 20,000 treatment courses of ledipasvir-sofosbuvir (Harvoni) annually at no cost.

No hay comentarios:

Publicar un comentario